Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2014, Article ID 926510, 6 pages
http://dx.doi.org/10.1155/2014/926510
Case Report

Late-Onset Glycogen Storage Disease Type II (Pompe’s Disease) with a Novel Mutation: A Malaysian Experience

1Department of Neurology, Kuala Lumpur General Hospital, Jalan Pahang, 50586 Kuala Lumpur, Malaysia
2Molecular Diagnostics and Protein Unit, Institute for Medical Research (IMR), Jalan Pahang, 50586 Kuala Lumpur, Malaysia
3Department of Genetics, Kuala Lumpur General Hospital, Jalan Pahang, 50586 Kuala Lumpur, Malaysia
4Department of Pathology, University of Malaya, Lembah Pantai, 50603 Kuala Lumpur, Malaysia

Received 26 February 2014; Accepted 3 June 2014; Published 30 June 2014

Academic Editor: Massimiliano Filosto

Copyright © 2014 Hiew Fu Liong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Leslie and B. T. Tinkle, “Glycogen storage disease type II (pompe disease),” GeneReviews, 2007. View at Google Scholar
  2. R. Hirschhorn and A. J. J. Reuser, “Glycogen storage disease type II: (acid maltase) deficiency,” in The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID), C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle, and B. Vogelstein, Eds., chapter 135, McGraw-Hill, New York, NY, USA, 2013. View at Google Scholar
  3. L. H. Hoefsloot, M. Hoogeveen-Westerveld, A. J. J. Reuser, and B. A. Oostra, “Characterization of the human lysosomal α-glucosidase gene,” Biochemical Journal, vol. 272, no. 2, pp. 493–497, 1990. View at Google Scholar · View at Scopus
  4. C. C. Yang, Y. H. Chien, N. C. Lee et al., “Rapid progressive course of later-onset Pompe disease in Chinese patients,” Molecular Genetics and Metabolism, vol. 104, no. 3, pp. 284–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Qiu J. J., M. Wei, W. M. Zhang, J. J. Qiu, Y. Meng, and Z. Q. Qiu, “Clinical and molecular genetic study on two patients of the juvenile form of Pompe disease in China,” Zhonghua er ke za zhi, vol. 45, no. 10, pp. 760–764, 2007. View at Google Scholar
  6. L. Wan, C.-C. Lee, C.-M. Hsu et al., “Identification of eight novel mutations of the acid α-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II,” Journal of Neurology, vol. 255, no. 6, pp. 831–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hagemans, L. Winkel, P. van Doorn et al., “Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients,” Brain, vol. 128, no. 3, pp. 671–677, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Müller-Felber, R. Horvath, K. Gempel et al., “Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients,” Neuromuscular Disorders, vol. 17, no. 9-10, pp. 698–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. F. Boerkoel, R. Exelbert, C. Nicastri et al., “Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II,” American Journal of Human Genetics, vol. 56, no. 4, pp. 887–897, 1995. View at Google Scholar · View at Scopus
  10. A. Herzog, R. Hartung, A. J. J. Reuser et al., “A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations,” Orphanet Journal of Rare Diseases, vol. 7, no. 1, article 35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. E. Slonim, R. A. Coleman, M. A. McElligot et al., “Improvement of muscle function in acid maltase deficiency by high-protein therapy,” Neurology, vol. 33, no. 1, pp. 34–38, 1983. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Margolis and A. R. Hill, “Acid maltase deficiency in an adult. Evidence for improvement in respiratory function with high-protein dietary therapy,” American Review of Respiratory Disease, vol. 134, no. 2, pp. 328–331, 1986. View at Google Scholar · View at Scopus
  13. J. M. Pascual and C. R. Roe, “Systemic metabolic abnormalities in adult-onset acid maltase deficiency beyond muscle glycogen accumulation,” JAMA Neurology, vol. 70, no. 6, pp. 756–763, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. O. A. F. Bodamer, J. V. Leonard, and D. Halliday, “Dietary treatment in late-onset acid maltase deficiency,” European Journal of Pediatrics, vol. 156, no. 1, pp. S39–S42, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Strothotte, N. Strigl-Pill, B. Grunert et al., “Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial,” Journal of Neurology, vol. 257, no. 1, pp. 91–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. T. van der Ploeg, P. R. Clemens, D. Corzo et al., “A randomized study of alglucosidase alfa in late-onset Pompe's disease,” The New England Journal of Medicine, vol. 362, no. 15, pp. 1396–1406, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. P. S. Kishnani, D. Corzo, M. Nicolino et al., “Recombinant human acid α-glucosidase: major clinical benefits in infantile-onset Pompe disease,” Neurology, vol. 68, no. 2, pp. 99–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Toscano and B. Schoser, “Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review,” Journal of Neurology, vol. 260, no. 4, pp. 951–959, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Güngör, M. E. Kruijshaar, I. Plug et al., “Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study,” Orphanet Journal of Rare Diseases, vol. 8, no. 49, no. 1, 2013. View at Publisher · View at Google Scholar · View at Scopus